Primary urethral malignant melanoma is an extremely rare malignancy with early metastasis and often delayed diagnosis, resulted in poor prognosis. Literature on this entity, especially with regard to urinary cytology is limited. We report here an extremely rare case of primary urethral malignant melanoma (MM) developed in a 95-year-old Japanese woman. A urinalysis showed macrophages containing brown granular pigments, and the urinary cytology was positive for atypical cells containing brown pigments suggestive of MM. Pathological examination of the biopsy specimen from the tumor revealed MM of the urethra. Immunohistochemically, the tumor cells showed strong cytoplasmic reactivities against antibodies, HMB-45 and Malan-A. Melanoma cells were immunohistochemically positive for c-Kit in their cytoplasm and cell membrane, although mutations in BRAF V600E and N/K-RAS were not detected. The urinary cytology and immunohistochemistry were useful for the rapid and accurate diagnosis for the urethral MM.
Case Report
A 95-year-old female, gravida four para four, presented to our hospital with intermittent vaginal spotting for several weeks. She had no history of urogenital symptoms or diseases, although she had hypertension. On physical examination, there was a mass protruding from the urethral meatus. It was 28 × 15 mm in diameter, tan colored and hemorrhagic ( Figure 1) . A urinalysis showed macrophages containing brown granular pigments (Figure 2(a) ), and the urinary cytology showed Figure 1 . A tan colored tumor with hemorrhage, measuring 28 × 15 mm, which projects from the urethra inside is observed. (Figure 4 ), but the whole body CT showed no metastases. Although unstained tumor tissue sections (10 μm thick) were used for examining mutations in N/K-RAS (codon 12, 13, 59, 61, 117, 146) and BRAF V600E genes by the PCR-rSSO method, we did not detect the mutations. The patient and her family did not wish further therapies, when considering her age. She received a herbal medicine, "Juzen-taiho-to" and a Lactobacillus casei medicine, "Biolactis powder", which was reported to have prophylactic effect on recurrence of bladder cancer [16] . Although surgical resection of the tumor was not performed in this case, staging grouping of this tumor was considered to be Stage III (T3aN0M0). Nine months after the first visit, the patient was alive with an intermittent vaginal spotting and the tumor did not grow-up.
Discussion
It is considered that primary MMs of the genitourinary tract arise from ectopic melanocytes which arrest in the urothelium during the embryonic migration from the neural crest [17] . To date, there are a few systematic reviews on this malignancy in English literature: 150 cases [9] and 36 cases [18] . The most frequent presentation was urethral mass the meatus [9] [18] , as presented in the present case. Although the first line of treatment was surgery (tumor excision or total urethrectomy) [9] [18], our patient did not agree with surgical resection of the tumor. Primary urethral MM is three times more common in women than men and tends to occur in old patients, averaging 65 years [8] [9] [10] . The female predominance might be a higher concentration of melanocytes in the mucocutaneous tissue of the vulva [19] . Most MMs of the female urethra are located at the meatus and/or in the distal urethra [11] , as shown in this case. The age (95-year-old) of our case is one of the highest in the English literature [8] [9] [10].
The urethral MMs may be easily confused with caruncle [20] , and are frequently misdiagnosed clinically, which leads to delayed diagnosis [21] . Thus, patients with the urethral MMs usually show a poor prognosis [21] . Primary MM of the female urethra tends to metastasize at early stage via the superficial lymphatics to the vulva and vagina to the inguinal lymph nodes by the deep lymphatics and occasionally to distal sites by the haematogenous route [22] . The urinalysis of the present case showed melanophages, and the urinary cytology was positive for melanoma cells at the first visit. On the same day, pathological diagnosis on the biopsy specimen obtained from the urethral tumor revealed the MM. As we experienced [14] , immunohistochemical examination using most frequently utilized melanocytic markers, HMB-45 and Melan-A, was useful for the accurate diagnosis of MMs. The monoclonal antibody, HMB-45, is quite specific melanocytic neoplasms, and Melan-A also reacts with more than 75% of melanomas [23] [24] [25] . In the present case, strong immunoreactivity against HMB-45
and Melan-A was found and the findings were useful for the diagnosis of the urethral MM, leading the early and accurate diagnosis. The patient had no metastases at the diagnosis, although she did not wish further therapies for this malignancy.
MRI can be used for diagnosis of urethral MM and evaluation of the tumor extent [26] [27] . Melanin may not follow the same MRI intensity pattern as other urethral tumors, since its appearance may depend on the intralesional melanin content [27] . In the present case, the intralesional melanin content was relatively rich, thus the lesion was recognized at the urethral meatus on the T1 high intensity.
Melanoma developed in the female urogenital region is a rare neoplasm with poor prognosis [28] . While BRAF V600E is known to be the most common pathogenic mutation found in melanoma in the sun-exposed skin, mucosal and genitourinary melanomas usually lack mutations in BRAF V600E, but harbor c-KIT mutations [28] . As to N-RAS, melanomas of the female urogenital tract, mutations in N-RAS are relatively common [29] . In this case, we did not found mutations of BRAF V600E and N/K-RAS in the tumor. However, immunohistochemical expression of c-Kit was noticed in the cytoplasm and cell membrane of melanoma cells, suggesting that targeted therapy against C-KIT activating mutations may be promising treatment [30] [31].
Conclusion
We report here an extremely rare case of primary malignant urethral melanoma developed in a 95-year-old Japanese woman. Urinalysis and urinary cytology were useful for our final diagnosis, urethral MM. Immunohistochemically, the tumor cells showed strong cytoplasmic reactivities for HMB-45 and Malan-A. The urinary cytology and immunohistochemistry for HMB-45 and Malan-A were useful for the early and accurate diagnosis for the urethral MM.
